Medical News

RSS

IDF commends Illinois advisory committee for unanimous vote to recommend SCID Newborn Screening

The Illinois Genetic and Metabolic Diseases Advisory Committee voted unanimously to recommend that the Department of Health screen all newborns for Severe Combined Immune Deficiency (SCID) - commonly known as bubble boy disease.

9 Feb 2011

Over 45 telemedicine networks under management of InTouch Health

InTouch Health® today announced that more than 45 telemedicine networks are currently under management. In total, these networks represent 475 contracted hospital locations where 375 are delivering telemedicine clinical services and the remaining 100 are undergoing pre-installation planning. InTouch Health provides complete telemedicine solutions that allow physicians to remotely perform real-time consults with hospital patients.

9 Feb 2011

East Texas Medical Center implements Unibased Consumer Access and Scheduling for Healthcare patient portal

Unibased Systems Architecture (Unibased), delivering market-leading enterprise scheduling and surgery management solutions to improve access and coordination of care, announced today that East Texas Medical Center (ETMC) has implemented the Unibased patient portal, Consumer Access and Scheduling for Healthcare (CASH).

9 Feb 2011

d-Wise launches innovative, web-based search platform for clinical data systems

d-Wise, provider of powerful business solutions for the unique challenges of the Life Sciences & Healthcare industries, has introduced Reveal, an innovative, web-based search platform that quickly returns results across multiple clinical data systems.

9 Feb 2011

NCCN praises Aetna for evidence-based approach to treat cancer

The National Comprehensive Cancer Network® (NCCN) has praised Aetna for its evidence-based approach to drugs used to treat cancer. The NCCN also acknowledged Aetna's commitment to providing health benefits to members enrolled in clinical trials. Aetna is the first national health plan to be recognized by the group.

9 Feb 2011

Zogenix receives 2011 DDP Industry Achievement Award for SUMAVEL DosePro

Zogenix, Inc. today announced that it has received the 2011 Drug Delivery Partnerships™ ("DDP") Innovation Award in the Industry Achievement category for SUMAVEL DosePro (sumatriptan injection) Needle-free Delivery System.

9 Feb 2011

Protect Pharma completes sale of two patents and patents-applications to Grunenthal

Protect Pharmaceutical Corporation announced that it has completed the sale of two patents and patents-applications to Grunenthal GmbH, a German specialty pharmaceutical company that is a pioneer in pain drug discovery and research. The patent portfolio includes innovative pain drugs that address the large and underserved pain market.

9 Feb 2011

Clinical Data reports $2.0 million revenue for third quarter 2011

Clinical Data, Inc. today announced operational and financial results for the third fiscal quarter ended December 31, 2010. The Company received approval from the U.S. Food and Drug Administration (FDA) of Viibryd™ for the treatment of adults with major depressive disorder (MDD) on January 21, 2011.

9 Feb 2011

PolyMedix commences PMX-60056 Phase 2 clinical trial in patients undergoing PCI

PolyMedix, Inc., an emerging biotechnology company focused on developing new therapeutic drugs to treat infectious diseases and acute cardiovascular disorders, has initiated a Phase 2 clinical trial, following conclusion of a review by the United States Food and Drug Administration (FDA) of a protocol submitted by PolyMedix, to assess the safety and efficacy of its heptagonist, PMX-60056, in reversing heparin in patients undergoing Percutaneous Coronary Intervention (PCI) procedures.

9 Feb 2011

Repligen third quarter total revenue increases 26% to $7,068,000

Repligen Corporation today reported results for the third quarter of fiscal year 2011, ended December 31, 2010. Total revenue for the quarter was $7,068,000 compared to total revenue of $5,617,000 for the third quarter of fiscal year 2010 ended December 31, 2009, an increase of $1,451,000 or 26%.

9 Feb 2011

GeoVax opens second HIV clinical trial site at Alabama Vaccine Research Clinic

GeoVax Labs, Inc., a biotechnology company that creates, develops and tests innovative HIV/AIDS vaccines, announced today the opening of a second clinical trial site at the Alabama Vaccine Research Clinic (AVRC) of the University of Alabama at Birmingham (UAB) to expand the company's HIV therapeutic vaccine trial.

9 Feb 2011

CeNeRx announces FDA approval of CXB909 IND for neuroprotection and neurodegenerative disorders

CeNeRx BioPharma, Inc., a clinical-stage company developing and commercializing innovative treatments for diseases of the central nervous system (CNS), today announced FDA approval of its IND and reported the first clinical results in humans for CXB909, a novel agent that has demonstrated utility in preclinical models of neuroprotection and neurodegenerative disorders.

9 Feb 2011

First Edition: February 9, 2011

Today's headlines include news about GOP plans to defund the health law and stepped up Capitol Hill activity surrounding the abortion issue.

9 Feb 2011

Virtues of Patient Protection and Affordable Care Act a 'mixed bag' for older Americans

Although the effects of the controversial health care reform act will be somewhat muted for many older Americans, it will inevitably have enough of an impact that seniors will discover that there is plenty to like and dislike about the law, a University of Illinois expert on elder law cautions in published research.

9 Feb 2011

DiaTech, Walter Reed collaborate to determine the best chemotherapy for cancer

DiaTech Oncology announced today they have engaged in a pilot with Walter Reed Army Medical Center to determine the best Chemotherapy for Cancer patients. Medical and GYN Oncologists and from Walter Reed have been working with DiaTech Oncology (Nashville, TN) using the MiCK assay for apoptosis in order to give physicians a tool that can predict the best chemotherapy pathway in treating cancer patients.

9 Feb 2011

BBSRC, EMBL-EBI applaud funding allocation for European Life-science Infrastructure for Biological Information

The Biotechnology and Biological Sciences Research Council (BBSRC) and the European Molecular Biology Laboratory's European Bioinformatics Institute (EMBL-EBI) welcome news that funding has been earmarked from the UK's Large Facilities Capital Fund for ELIXIR - the European Life-science Infrastructure for Biological Information - as announced today (09 February 2011).

9 Feb 2011

A.P. Pharma provides update on response to APF530 Complete Response Letter

A.P. Pharma, Inc., a specialty pharmaceutical company, today provided an update on its progress toward responding to the Complete Response Letter for APF530 that the Company received from the U.S. Food and Drug Administration (FDA) in March 2010.

9 Feb 2011

Single molecule imaging movies of living cell membranes clarify enigma surrounding receptor molecule behaviors

Unprecedented single molecule imaging movies of living cell membranes, taken by a research team based at Kyoto University and the University of New Mexico, have clarified a decades-old enigma surrounding receptor molecule behaviors. The results, appearing in the latest issue of the Journal of Cell Biology, promise to open the door to new possibilities for drug development.

9 Feb 2011

Iworx introduces 2011 Product Catalog of physiology teaching and advanced research solutions

iWorx, a developer of advanced physiology research and teaching tools, has introduced its 2011 Product Catalog of physiology teaching and advanced research solutions.

9 Feb 2011

Rapid detection of transiently folded single-molecule structures from 'intrinsically disordered proteins'

A team of scientists from The Scripps Research Institute and the University of California, San Diego (UCSD) have developed a novel technique to observe previously unknown details of how folded structures are formed from an intrinsically disordered protein. The insights could help scientists to better understand the mechanism of plaque formation in neurodegenerative disorders such as Parkinson's and Alzheimer's diseases.

9 Feb 2011

Medical News

IDF commends Illinois advisory committee for unanimous vote to recommend SCID Newborn Screening

Over 45 telemedicine networks under management of InTouch Health

East Texas Medical Center implements Unibased Consumer Access and Scheduling for Healthcare patient portal

d-Wise launches innovative, web-based search platform for clinical data systems

NCCN praises Aetna for evidence-based approach to treat cancer

Zogenix receives 2011 DDP Industry Achievement Award for SUMAVEL DosePro

Protect Pharma completes sale of two patents and patents-applications to Grunenthal

Clinical Data reports $2.0 million revenue for third quarter 2011

PolyMedix commences PMX-60056 Phase 2 clinical trial in patients undergoing PCI

Repligen third quarter total revenue increases 26% to $7,068,000

GeoVax opens second HIV clinical trial site at Alabama Vaccine Research Clinic

CeNeRx announces FDA approval of CXB909 IND for neuroprotection and neurodegenerative disorders

First Edition: February 9, 2011

Virtues of Patient Protection and Affordable Care Act a 'mixed bag' for older Americans

DiaTech, Walter Reed collaborate to determine the best chemotherapy for cancer

BBSRC, EMBL-EBI applaud funding allocation for European Life-science Infrastructure for Biological Information

A.P. Pharma provides update on response to APF530 Complete Response Letter

Single molecule imaging movies of living cell membranes clarify enigma surrounding receptor molecule behaviors

Iworx introduces 2011 Product Catalog of physiology teaching and advanced research solutions

Rapid detection of transiently folded single-molecule structures from 'intrinsically disordered proteins'

Advancing Motor Neuron Disease Diagnosis with Non-Invasive Ultrasound and AI

How agentic AI is reshaping laboratory workflows

Fourier 80: bringing benchtop NMR systems to the laboratory

Latest News